Stockscreener 앱 받기
1.46
0.69%
0.01
시간 외 거래:
1.48
0.02
+1.37%
전일 마감가:
$1.45
열려 있는:
$1.45
하루 거래량:
8.77M
Relative Volume:
3.51
시가총액:
$388.57M
수익:
-
순이익/손실:
$-208.38M
주가수익비율:
-1.2167
EPS:
-1.2
순현금흐름:
$-156.57M
1주 성능:
-2.67%
1개월 성능:
-38.40%
6개월 성능:
-29.13%
1년 성능:
-67.12%
1일 변동 폭
$1.40
$1.47
1주일 범위
$1.39
$1.5499
52주 변동 폭
$1.105
$5.00
Autolus Therapeutics Plc Adr Stock (AUTL) Company Profile
명칭
Autolus Therapeutics Plc Adr
전화
44 20 3829 6230
주소
THE MEDIAWORKS, LONDON
AUTL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AUTL
Autolus Therapeutics Plc Adr
|
1.46 | 385.91M | 0 | -208.38M | -156.57M | -1.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Autolus Therapeutics Plc Adr Stock (AUTL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-18 | 업그레이드 | Goldman | Neutral → Buy |
| 2024-11-15 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2023-11-09 | 개시 | Deutsche Bank | Buy |
| 2023-03-27 | 재개 | Wells Fargo | Overweight |
| 2023-03-17 | 개시 | Bryan Garnier | Buy |
| 2021-06-14 | 업그레이드 | Jefferies | Hold → Buy |
| 2021-01-29 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-12-28 | 재개 | H.C. Wainwright | Buy |
| 2020-07-31 | 개시 | JP Morgan | Overweight |
| 2020-07-22 | 개시 | SunTrust | Buy |
| 2020-04-22 | 개시 | Mizuho | Buy |
| 2019-09-23 | 개시 | Needham | Buy |
| 2019-05-17 | 재확인 | H.C. Wainwright | Buy |
| 2018-10-24 | 개시 | H.C. Wainwright | Buy |
모두보기
Autolus Therapeutics Plc Adr 주식(AUTL)의 최신 뉴스
Autolus Therapeutics Q2 Earnings Call Highlights Growth and Challenges - AInvest
Real time pattern detection on World Acceptance Corporation stockJuly 2025 WrapUp & Free Technical Pattern Based Buy Signals - Newser
Aug Macro: What is the next catalyst for The Toronto Dominion BankRate Cut & Reliable Momentum Entry Alerts - خودرو بانک
How to track smart money flows in BNZIJuly 2025 Volume & AI Optimized Trade Strategies - Newser
PLOW recovery potential after sell offWeekly Investment Report & Growth Oriented Trading Recommendations - Newser
Price momentum metrics for HIG.PRG explainedMarket Trend Report & Growth Focused Entry Reports - Newser
Analyzing recovery setups for Autolus Therapeutics plc Depositary Receipt investorsRate Hike & High Accuracy Buy Signal Tips - Newser
Applying Elliott Wave Theory to Travel + Leisure Co.July 2025 Rallies & Comprehensive Market Scan Reports - Newser
AUTL’s Market Quandary: Decoding the Ups and Downs of 2025 - investchronicle.com
Can machine learning forecast MNDR recoveryJuly 2025 EndofMonth & Real-Time Sentiment Analysis - Newser
What makes TFIN stock price move sharplyJuly 2025 Macro Moves & Advanced Technical Signal Analysis - Newser
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Given Average Recommendation of “Buy” by Brokerages - Defense World
Q3 EPS Forecast for Autolus Therapeutics Raised by Analyst - Defense World
Wells Fargo & Company Has Lowered Expectations for Autolus Therapeutics (NASDAQ:AUTL) Stock Price - Defense World
Cetera Investment Advisers Raises Stock Position in Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) - Defense World
Autolus Therapeutics (NASDAQ:AUTL) Shares Down 3.5% After Analyst Downgrade - Defense World
Autolus reports $20.9 million in Q2 2025 AUCATZYL revenue - Investing.com India
Will Albertsons Companies Inc. stock recover after recent dropFree Entry and Exit Strategy Optimizer Tool - Newser
Autolus Therapeutics Reports Second Quarter 2025 Financial Results and Business Updates - GlobeNewswire Inc.
How GLDD stock performs during market volatilityAlgorithmic Forecast for Swing Trading Picks - Newser
Autolus Therapeutics Q2 2025 Earnings Call Transcript - MarketBeat
Why IGNEP stock attracts strong analyst attentionFree Day Trading Signals With High Precision - Newser
When is the best time to buy GRAIL LLC stockFree Smart Allocation Stock Pick Insights - Newser
Is a relief rally coming for Zhibao Technology Inc. holdersSmart Stock Forecast Using AI Algorithms - Newser
Statistical indicators supporting GDV.PRH’s strengthFree Stable Entry High Return Opportunities - Newser
Can machine learning forecast Peoples Bancorp of North Carolina Inc. recoveryHigh Win Rate Strategy with Stop Protection - Newser
What makes Boqii Holding Limited Depositary Receipt stock price move sharplyFree Market Entry and Exit Point Tips - Newser
Autolus Therapeutics plc ADR: Weathering Stock Market Storms with 637.41M Market Cap - investchronicle.com
LyondellBasell Industries NV (LYB) Stock: A Year of Stock Market Ups and Downs - investchronicle.com
Top chart patterns to watch in Stevanato Group S.p.A.Free High Return Stock Focus With Safety - Newser
P 500Real-Time Equity Price Action Analysis - Newser
Unlocking Oncology’s Future: 3 Trending Cancer Biotech Stocks With ‘Strong Buy’ Ratings - Barchart.com
TER’s Stock Market Adventure: -40.87% YTD Growth Amidst Volatility - investchronicle.com
Globe Life Inc (GL) Stock: Navigating a Year of Volatility - investchronicle.com
Autolus Therapeutics’ (AUTL) Buy Rating Reaffirmed at Needham & Company LLC - Defense World
European Commission approves Autolus’ cell therapy for adult leukemia By Investing.com - Investing.com South Africa
European Commission approves Autolus’ cell therapy for adult leukemia - Investing.com India
Will A Mark Precious Metals Inc. stock benefit from interest rate changesDaily Upside Movement Prediction With Data - Newser
Autolus Therapeutics Grants Stock Options to 60 Employees Under 2025 Inducement Plan - Nasdaq
Cambridge Investment Research Advisors Inc. Sells 2,160 Shares of Invesco KBW Property & Casualty Insurance ETF (NASDAQ:KBWP) - Defense World
Allspring Global Investments Holdings LLC Sells 439,622 Shares of Dr. Reddy’s Laboratories Ltd (NYSE:RDY) - Defense World
1,867 Shares in Axsome Therapeutics, Inc. (NASDAQ:AXSM) Bought by DAVENPORT & Co LLC - Defense World
DAVENPORT & Co LLC Trims Holdings in Janus Henderson Short Duration Income ETF (NYSEARCA:VNLA) - Defense World
Vontobel Holding Ltd. Lowers Holdings in Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) - Defense World
Allspring Global Investments Holdings LLC Raises Holdings in Broadstone Net Lease, Inc. (NYSE:BNL) - Defense World
Wealth Enhancement Advisory Services LLC Takes $258,000 Position in Taylor Morrison Home Corporation (NYSE:TMHC) - Defense World
Vontobel Holding Ltd. Buys 49,643 Shares of Tilray Brands, Inc. (NASDAQ:TLRY) - Defense World
TELUS International (Cda) (TSE:TIXT) Trading 2.1% Higher – What’s Next? - Defense World
Closing Figures: Autolus Therapeutics plc ADR (AUTL)’s Negative Finish at 2.05, Down -3.30 - DWinneX
NOV Inc: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio - investchronicle.com
Autolus shares surge 77% following InvestingPro’s April Fair Value signal By Investing.com - Investing.com India
Autolus Therapeutics Plc Adr (AUTL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):